These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 3102156)

  • 21. Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.
    Kádár B; Kocsis B; Tóth Á; Damjanova I; Szász M; Kristóf K; Nagy K; Szabó D
    Acta Microbiol Immunol Hung; 2013 Jun; 60(2):201-9. PubMed ID: 23827751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antimicrobial susceptibility of phenotypically extended spectrum beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii isolates].
    Metan G; Zarakolu P; Hasçelik G; Akova M
    Mikrobiyol Bul; 2006; 40(1-2):23-8. PubMed ID: 16775953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa.
    D'Souza BB; Padmaraj SR; Rekha PD; Tellis RC; Prabhu S; Pothen P
    Microb Drug Resist; 2014 Dec; 20(6):550-4. PubMed ID: 25055029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
    Philippon A
    Chemioterapia; 1985 Dec; 4(6):424-8. PubMed ID: 3938346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS; Pressler T; Jensen T; Rosdahl VT; Bentzon MW; Høiby N; Koch C
    J Antimicrob Chemother; 1987 Jan; 19(1):101-7. PubMed ID: 3104273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
    Watanakunakorn C
    J Antimicrob Chemother; 1986 Jan; 17(1):91-5. PubMed ID: 3081474
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Goodlet KJ; Nicolau DP; Nailor MD
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro synergism of ceftriaxone combined with aminoglycosides against Pseudomonas aeruginosa.
    Laverdière M; Gallimore B; Restieri C; Poonia K; Chow AW
    Diagn Microbiol Infect Dis; 1994 May; 19(1):39-46. PubMed ID: 7956011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.
    Flynn CM; Johnson DM; Jones RN
    J Chemother; 1996 Dec; 8(6):411-5. PubMed ID: 8981179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.
    den Hollander JG; Horrevorts AM; van Goor ML; Verbrugh HA; Mouton JW
    Antimicrob Agents Chemother; 1997 Jan; 41(1):95-100. PubMed ID: 8980762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia.
    Kumar A; Hay MB; Maier GA; Dyke JW
    J Antimicrob Chemother; 1992 Nov; 30(5):597-602. PubMed ID: 1283606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Apr; 42(4):953-5. PubMed ID: 9559819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
    Iaconis JP; Pitkin DH; Sheikh W; Nadler HL
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S191-6. PubMed ID: 9126693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas aeruginosa: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1988; 34(4):284-97. PubMed ID: 3145172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Balke B; Hogardt M; Schmoldt S; Hoy L; Weissbrodt H; Häussler S
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):25-30. PubMed ID: 16402226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.
    Jahangiri A; Neshani A; Mirhosseini SA; Ghazvini K; Zare H; Sedighian H
    Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro activity of meropenem, a new carbapenem, against imipenem-resistant Pseudomonas aeruginosa and Xanthomonas maltophilia.
    García-Rodríguez JA; García Sánchez JE; Muñoz Bellido JL; García Sánchez E; García García MI
    J Chemother; 1991 Jun; 3(3):143-6. PubMed ID: 1919651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany.
    Schülin T
    J Antimicrob Chemother; 2002 Feb; 49(2):403-6. PubMed ID: 11815589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro comparison of cefpirome and four other beta-lactam antibiotics alone and in combination with tobramycin against clinical isolates of Pseudomonas aeruginosa.
    Cabezudo I; Pfaller M; Bale M; Wenzel R
    Diagn Microbiol Infect Dis; 1989; 12(4):337-41. PubMed ID: 2512048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran.
    Malekzadegan Y; Abdi A; Heidari H; Moradi M; Rastegar E; Sedigh Ebrahim-Saraie H
    BMC Res Notes; 2019 May; 12(1):301. PubMed ID: 31138309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.